<?xml version="1.0" encoding="UTF-8"?>
<search_results count="1046">
  <query>SEARCH[STUDY] ( Crohn's Disease [STUDY:ALL-FIELDS] )</query>
  <clinical_study>
    <order>901</order>
    <score>0.24099</score>
    <nct_id>NCT02699333</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02699333</url>
    <title>Risk Factors for Microscopic Colitis</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Colitis, Microscopic</condition_summary>
    <last_changed>September 7, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>902</order>
    <score>0.24089</score>
    <nct_id>NCT01797224</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01797224</url>
    <title>OTIS Autoimmune Diseases in Pregnancy Project</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn's Disease; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis</condition_summary>
    <last_changed>March 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>903</order>
    <score>0.24088</score>
    <nct_id>NCT02265588</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02265588</url>
    <title>Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease (IBD); Ulcerative Colitis; Crohn's Disease; Anxiety; Depression</condition_summary>
    <intervention_summary>Behavioral: Cognitive behavioral therapy</intervention_summary>
    <last_changed>March 3, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>904</order>
    <score>0.24034</score>
    <nct_id>NCT02461758</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02461758</url>
    <title>Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease (IBD)</condition_summary>
    <intervention_summary>Biological: Influenza vaccine</intervention_summary>
    <last_changed>November 29, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>905</order>
    <score>0.24024</score>
    <nct_id>NCT00534911</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00534911</url>
    <title>Reducing Depressive Symptoms in Physically Ill Youth</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Depression</condition_summary>
    <intervention_summary>Behavioral: Cognitive Behavioral Therapy; Behavioral: Supportive Non-directive Therapy (SNDT)</intervention_summary>
    <last_changed>May 1, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>906</order>
    <score>0.2397</score>
    <nct_id>NCT02333526</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02333526</url>
    <title>Syndecan 1 as Biomarker for Inflammation</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Colitis</condition_summary>
    <last_changed>February 28, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>907</order>
    <score>0.23944</score>
    <nct_id>NCT00517101</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00517101</url>
    <title>Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy</title>
    <status open="N">Unknown status</status>
    <condition_summary>Psoriatic Arthritis; Ankylosing Spondylitis; Undifferentiated Spondyloarthropathy</condition_summary>
    <last_changed>August 15, 2007</last_changed>
  </clinical_study>
  <clinical_study>
    <order>908</order>
    <score>0.23824</score>
    <nct_id>NCT02712866</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02712866</url>
    <title>Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Vedolizumab</intervention_summary>
    <last_changed>June 3, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>909</order>
    <score>0.23723</score>
    <nct_id>NCT03082287</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03082287</url>
    <title>ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Device: Fecal Calprotectin Level</intervention_summary>
    <last_changed>June 27, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>910</order>
    <score>0.23655</score>
    <nct_id>NCT01560819</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01560819</url>
    <title>Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease (IBD)</condition_summary>
    <intervention_summary>Drug: Gut Microbial Transplantation</intervention_summary>
    <last_changed>December 4, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>911</order>
    <score>0.23482</score>
    <nct_id>NCT02822352</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02822352</url>
    <title>RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Ulcerative Colitis; Crohn's Colitis</condition_summary>
    <intervention_summary>Other: Chromoendoscopy</intervention_summary>
    <last_changed>August 18, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>912</order>
    <score>0.23463</score>
    <nct_id>NCT00259558</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00259558</url>
    <title>Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: retarded release phosphatidylcholine</intervention_summary>
    <last_changed>February 7, 2007</last_changed>
  </clinical_study>
  <clinical_study>
    <order>913</order>
    <score>0.23462</score>
    <nct_id>NCT01658605</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01658605</url>
    <title>A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Colitis, Ulcerative</condition_summary>
    <intervention_summary>Drug: GSK1605786; Other: Placebo</intervention_summary>
    <last_changed>June 20, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>914</order>
    <score>0.23437</score>
    <nct_id>NCT01790061</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01790061</url>
    <title>Standardized Fecal Microbiota Transplantation for Ulcerative Colitis</title>
    <status open="N">Unknown status</status>
    <condition_summary>Bacteria; Microbiota; Fecal Microbiota Transplantation; Inflammatory Bowel Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Procedure: Standardized Fecal Microbiota Transplantation; Drug: Traditional treatments according to associated guidelines</intervention_summary>
    <last_changed>November 21, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>915</order>
    <score>0.23428</score>
    <nct_id>NCT01981343</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01981343</url>
    <title>A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.</title>
    <status open="N">Unknown status</status>
    <condition_summary>Gallbladder</condition_summary>
    <intervention_summary>Dietary Supplement: A-F Betafood; Other: Placebo</intervention_summary>
    <last_changed>December 23, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>916</order>
    <score>0.23415</score>
    <nct_id>NCT00663247</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00663247</url>
    <title>Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Diverticulosis, Colonic</condition_summary>
    <intervention_summary>Device: Mesalazine; Drug: Placebo</intervention_summary>
    <last_changed>June 13, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>917</order>
    <score>0.23384</score>
    <nct_id>NCT00224562</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00224562</url>
    <title>The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists</title>
    <status open="N">Unknown status</status>
    <condition_summary>Rheumatoid Arthritis; Crohn's Disease; Ankylosing Spondylitis; Psoriasis</condition_summary>
    <intervention_summary>Drug: TNF-alpha antagonists</intervention_summary>
    <last_changed>October 25, 2005</last_changed>
  </clinical_study>
  <clinical_study>
    <order>918</order>
    <score>0.23376</score>
    <nct_id>NCT01111292</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01111292</url>
    <title>Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia</title>
    <status open="N">Terminated</status>
    <condition_summary>Colon Carcinoma; Dysplasia in Crohn Disease; Low Grade Dysplasia in Ulcerative Colitis; Rectal Carcinoma</condition_summary>
    <intervention_summary>Drug: Inositol; Other: Placebo</intervention_summary>
    <last_changed>June 1, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>919</order>
    <score>0.23344</score>
    <nct_id>NCT01851343</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01851343</url>
    <title>Bone Marrow Stromal Cells for Inflammatory Bowel Diseases</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: Bone Marrow Stromal Cell (BMSC) Infusion</intervention_summary>
    <last_changed>July 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>920</order>
    <score>0.23316</score>
    <nct_id>NCT03220685</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03220685</url>
    <title>Relationship Between Gut Microbiota And Anemia In Chronic Kidney Disease (CKD) Patients</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Gut Micrbota and Its Relation to Anemia of CKD Patients</condition_summary>
    <intervention_summary>Biological: Stool analysis</intervention_summary>
    <last_changed>July 17, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>921</order>
    <score>0.23304</score>
    <nct_id>NCT01277419</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01277419</url>
    <title>German Spondyloarthritis Inception Cohort</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Ankylosing Spondylitis; Non-radiographic Axial Spondyloarthritis</condition_summary>
    <last_changed>March 11, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>922</order>
    <score>0.23278</score>
    <nct_id>NCT02352064</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02352064</url>
    <title>Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Chronic Graft Versus Host Disease</condition_summary>
    <intervention_summary>Procedure: PET (18-FDG)</intervention_summary>
    <last_changed>January 31, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>923</order>
    <score>0.23254</score>
    <nct_id>NCT00259545</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00259545</url>
    <title>Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis; Phosphatidylcholine</condition_summary>
    <intervention_summary>Drug: Retarded Release Phosphatidylcholine (rPC)</intervention_summary>
    <last_changed>June 4, 2008</last_changed>
  </clinical_study>
  <clinical_study>
    <order>924</order>
    <score>0.23227</score>
    <nct_id>NCT02734589</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02734589</url>
    <title>Pilot Study of Fecal Transplantation Using a Unique Diet for Donor and Recipient in Moderate to Severe Treatment Refractory Colitis in Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: Fecal transplantation; Other: Unique novel Diet for UC and Unique novel Diet for the donor + FMT; Other: Unique novel Diet for UC</intervention_summary>
    <last_changed>July 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>925</order>
    <score>0.23227</score>
    <nct_id>NCT00695682</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00695682</url>
    <title>Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)</title>
    <status open="N">Unknown status</status>
    <condition_summary>Diabetic Retinopathy; Macular Degeneration</condition_summary>
    <intervention_summary>Drug: intravitreal injection of infliximab</intervention_summary>
    <last_changed>June 11, 2008</last_changed>
  </clinical_study>
  <clinical_study>
    <order>926</order>
    <score>0.23217</score>
    <nct_id>NCT02382705</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02382705</url>
    <title>SB3 Battery Life Observational Study</title>
    <status open="N">Enrolling by invitation</status>
    <condition_summary>Capsule Endoscopy</condition_summary>
    <last_changed>June 14, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>927</order>
    <score>0.23215</score>
    <nct_id>NCT01858220</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01858220</url>
    <title>IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach</title>
    <status open="N">Unknown status</status>
    <condition_summary>Gastroparesis</condition_summary>
    <last_changed>February 24, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>928</order>
    <score>0.23073</score>
    <nct_id>NCT02199496</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02199496</url>
    <title>Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency</title>
    <status open="Y">Recruiting</status>
    <condition_summary>CVID; Enteropathy; Chronic Diarrhea; Maldigestion; Malabsorption</condition_summary>
    <intervention_summary>Biological: Ustekinumab</intervention_summary>
    <last_changed>July 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>929</order>
    <score>0.23036</score>
    <nct_id>NCT01393405</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01393405</url>
    <title>Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Methotrexate</intervention_summary>
    <last_changed>April 24, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>930</order>
    <score>0.22896</score>
    <nct_id>NCT00291681</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00291681</url>
    <title>Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>February 12, 2006</last_changed>
  </clinical_study>
  <clinical_study>
    <order>931</order>
    <score>0.22891</score>
    <nct_id>NCT01242163</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01242163</url>
    <title>Application of Chemical Sensors for Diagnosis of Inflammatory Bowel Diseases and Irritable Bowel Syndrome by Respiratory Samples</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Diseases; Irritable Bowel Syndrome</condition_summary>
    <last_changed>November 22, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>932</order>
    <score>0.22889</score>
    <nct_id>NCT03006393</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03006393</url>
    <title>Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Depression</condition_summary>
    <intervention_summary>Drug: Infliximab; Other: Placebo</intervention_summary>
    <last_changed>March 9, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>933</order>
    <score>0.22887</score>
    <nct_id>NCT02139709</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02139709</url>
    <title>Milk-derived Gangliosides for Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Dietary Supplement: Ganglioside; Dietary Supplement: Placebo</intervention_summary>
    <last_changed>June 2, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>934</order>
    <score>0.22863</score>
    <nct_id>NCT02970149</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02970149</url>
    <title>Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>IBD</condition_summary>
    <intervention_summary>Other: NA (observational)</intervention_summary>
    <last_changed>May 5, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>935</order>
    <score>0.22819</score>
    <nct_id>NCT01841099</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01841099</url>
    <title>Mesalamine in Environmental Enteropathy</title>
    <status open="N">Completed</status>
    <condition_summary>Malnutrition</condition_summary>
    <intervention_summary>Drug: Mesalamine; Drug: Placebo granules</intervention_summary>
    <last_changed>July 10, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>936</order>
    <score>0.2281</score>
    <nct_id>NCT01853267</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01853267</url>
    <title>Perianal Abscess Packing Randomized ControlledTrial Pilot Study</title>
    <status open="N">Completed</status>
    <condition_summary>Perianal Abscess</condition_summary>
    <intervention_summary>Procedure: Intervention Group (Non-Packing); Procedure: Control group (Packing)</intervention_summary>
    <last_changed>May 20, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>937</order>
    <score>0.228</score>
    <nct_id>NCT03131297</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03131297</url>
    <title>Multicenter Prospective Evaluation of Radiofrequency for Anal Fistulas</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Anal Fistula</condition_summary>
    <intervention_summary>Procedure: treatment by radiofrequency</intervention_summary>
    <last_changed>April 24, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>938</order>
    <score>0.2279</score>
    <nct_id>NCT03143517</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03143517</url>
    <title>Fecal Calprotectin Collection Protocol</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Ulcerative Colitis; Crohn Disease; Indeterminate Colitis; Chronic Diarrhea; Celiac Disease; Diverticulitis; Abdominal Pain; Distension; Weight Loss; Food Intolerance; Constipation</condition_summary>
    <intervention_summary>Diagnostic Test: Stool collection</intervention_summary>
    <last_changed>June 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>939</order>
    <score>0.22786</score>
    <nct_id>NCT02709434</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02709434</url>
    <title>Fatigue Management in Quiescent IBD</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Fatigue; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Behavioral: Psychoeducational programme; Other: Standard care</intervention_summary>
    <last_changed>March 11, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>940</order>
    <score>0.22774</score>
    <nct_id>NCT02987686</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02987686</url>
    <title>Topical Infliximab for Sterile Corneal Melt</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Sterile Corneal Melt</condition_summary>
    <intervention_summary>Drug: Topical Infliximab</intervention_summary>
    <last_changed>July 19, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>941</order>
    <score>0.22756</score>
    <nct_id>NCT01062815</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01062815</url>
    <title>Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants</title>
    <status open="N">Terminated</status>
    <condition_summary>Cholestasis; Prematurity; Gastroschisis; Intestinal Atresia; Necrotizing Enterocolitis</condition_summary>
    <intervention_summary>Dietary Supplement: Parenteral Nutrition</intervention_summary>
    <last_changed>November 20, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>942</order>
    <score>0.22755</score>
    <nct_id>NCT03208777</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03208777</url>
    <title>Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Tumor Gastric</condition_summary>
    <intervention_summary>Genetic: taking blood samples</intervention_summary>
    <last_changed>July 5, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>943</order>
    <score>0.22747</score>
    <nct_id>NCT00589771</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00589771</url>
    <title>Saccharomyces Boulardii in Irritable Bowel Syndrome</title>
    <status open="N">Completed</status>
    <condition_summary>Diarrhea Dominant Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Drug: Saccharomyces boulardii; Drug: Placebo</intervention_summary>
    <last_changed>October 14, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>944</order>
    <score>0.22735</score>
    <nct_id>NCT01295814</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01295814</url>
    <title>Efficacy Study of Adalimumab to Treat Interstitial Cystitis</title>
    <status open="N">Completed</status>
    <condition_summary>Interstitial Cystitis</condition_summary>
    <intervention_summary>Drug: Adalimumab; Other: inactive drug</intervention_summary>
    <last_changed>July 12, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>945</order>
    <score>0.22721</score>
    <nct_id>NCT00671138</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00671138</url>
    <title>Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity</title>
    <status open="N">Completed</status>
    <condition_summary>Celiac Disease</condition_summary>
    <intervention_summary>Biological: Necator americanus; Other: Sham inoculation</intervention_summary>
    <last_changed>January 31, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>946</order>
    <score>0.22718</score>
    <nct_id>NCT02391012</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02391012</url>
    <title>Fecal Transplantation for Inflammatory Bowel Disease</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Biological: Fecal microbial l transplantation</intervention_summary>
    <last_changed>June 13, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>947</order>
    <score>0.22673</score>
    <nct_id>NCT01441219</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01441219</url>
    <title>Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel</title>
    <status open="N">Terminated</status>
    <condition_summary>Gastrointestinal Hemorrhage</condition_summary>
    <intervention_summary>Device: Colon 2</intervention_summary>
    <last_changed>March 4, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>948</order>
    <score>0.22513</score>
    <nct_id>NCT00895336</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00895336</url>
    <title>Lactobacillus GG in Pediatric Ulcerative Colitis (UC)</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Biological: Lactobacillus GG</intervention_summary>
    <last_changed>February 6, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>949</order>
    <score>0.22469</score>
    <nct_id>NCT00228839</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00228839</url>
    <title>GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Graft vs Host Disease</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>June 29, 2009</last_changed>
  </clinical_study>
  <clinical_study>
    <order>950</order>
    <score>0.22444</score>
    <nct_id>NCT02872623</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02872623</url>
    <title>EnteroCT With Enteroclysis Versus Enterography-MRI for the Diagnosis of Tumors of the Small Intestine: a Pilot Study</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Suspicion of Tumor of the Small Intestine</condition_summary>
    <intervention_summary>Radiation: Enterography-MRI without enteroclysis; Radiation: enteroCT with enteroclysis</intervention_summary>
    <last_changed>August 29, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>951</order>
    <score>0.22423</score>
    <nct_id>NCT02872376</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02872376</url>
    <title>Clinical Burden of Anemia in Inflammatory Bowel Disease (RIDART1)</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Anemia</condition_summary>
    <last_changed>August 15, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>952</order>
    <score>0.22404</score>
    <nct_id>NCT02796339</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02796339</url>
    <title>A Study on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases.</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Dietary Supplement: Mastiha; Dietary Supplement: Placebo</intervention_summary>
    <last_changed>May 2, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>953</order>
    <score>0.22397</score>
    <nct_id>NCT01170715</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01170715</url>
    <title>Psoriasis Inflammation and Systemic Co Morbidities</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Psoriasis</condition_summary>
    <last_changed>January 6, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>954</order>
    <score>0.22394</score>
    <nct_id>NCT00461526</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00461526</url>
    <title>Diarrhea Predominant Irritable Bowel Syndrome in Females</title>
    <status open="N">Completed</status>
    <condition_summary>Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Drug: crofelemer</intervention_summary>
    <last_changed>November 19, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>955</order>
    <score>0.22386</score>
    <nct_id>NCT02857205</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02857205</url>
    <title>MICROPRUNG : Intestinal Microbiota Analysis in Patients With or Without Hirschsprung's Associated EnteroColitis</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Hirschsprung Disease</condition_summary>
    <intervention_summary>Other: Fecal samples</intervention_summary>
    <last_changed>August 2, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>956</order>
    <score>0.22375</score>
    <nct_id>NCT02502370</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02502370</url>
    <title>Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Small Bowel Adenocarcinoma; Adjuvant Chemotherapy for SBA</condition_summary>
    <intervention_summary>Drug: observation alone; Drug: LV5FU2; Drug: FOLFOX</intervention_summary>
    <last_changed>July 16, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>957</order>
    <score>0.22333</score>
    <nct_id>NCT00029042</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00029042</url>
    <title>Infliximab to Treat Children With Juvenile Rheumatoid Arthritis</title>
    <status open="N">Terminated</status>
    <condition_summary>Juvenile Rheumatoid Arthritis</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>August 26, 2008</last_changed>
  </clinical_study>
  <clinical_study>
    <order>958</order>
    <score>0.2231</score>
    <nct_id>NCT00727636</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00727636</url>
    <title>Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Biological: Gardasil vaccine</intervention_summary>
    <last_changed>May 3, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>959</order>
    <score>0.2228</score>
    <nct_id>NCT02025777</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02025777</url>
    <title>Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Device: Capsule Endoscopy</intervention_summary>
    <last_changed>March 2, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>960</order>
    <score>0.22266</score>
    <nct_id>NCT01314092</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01314092</url>
    <title>Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula</title>
    <status open="N">Terminated</status>
    <condition_summary>Complex Perianal Fistula</condition_summary>
    <intervention_summary>Biological: Autologous cultured adipose derived stem cells(low dose group); Biological: Autologous cultured adipose derived stem cells(high dose group)</intervention_summary>
    <last_changed>November 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>961</order>
    <score>0.22207</score>
    <nct_id>NCT00933296</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00933296</url>
    <title>Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors</title>
    <status open="N">Unknown status</status>
    <condition_summary>Schnitzler Syndrome</condition_summary>
    <last_changed>November 16, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>962</order>
    <score>0.22167</score>
    <nct_id>NCT01498406</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01498406</url>
    <title>Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus</title>
    <status open="N">Terminated</status>
    <condition_summary>Cutaneous Lupus Erythematosus</condition_summary>
    <intervention_summary>Dietary Supplement: vitamin D</intervention_summary>
    <last_changed>November 18, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>963</order>
    <score>0.22083</score>
    <nct_id>NCT01623453</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01623453</url>
    <title>Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)</title>
    <status open="N">Terminated</status>
    <condition_summary>Perianal Fistula; Primary; Complex</condition_summary>
    <intervention_summary>Biological: Autologous adipose derived stem cells(low dose group); Biological: Autologous adipose derived stem cells(high dose group)</intervention_summary>
    <last_changed>November 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>964</order>
    <score>0.21954</score>
    <nct_id>NCT01052376</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01052376</url>
    <title>Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease (IBD); Familial Adenomatous Polyposis</condition_summary>
    <intervention_summary>Device: Confocal endomicroscopy</intervention_summary>
    <last_changed>May 22, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>965</order>
    <score>0.21917</score>
    <nct_id>NCT02775656</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02775656</url>
    <title>UCB Cimzia Pregnancy Follow-up Study</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Rheumatoid Arthritis (RA); Crohn's Disease (CD); Psoriatic Arthritis (PsA); Axial Spondyloarthritis and Ankylosing Spondylitis</condition_summary>
    <last_changed>June 29, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>966</order>
    <score>0.21908</score>
    <nct_id>NCT00075075</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00075075</url>
    <title>Infliximab to Treat Non-Infectious Scleritis</title>
    <status open="N">Completed</status>
    <condition_summary>Scleritis</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>967</order>
    <score>0.21862</score>
    <nct_id>NCT02135289</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02135289</url>
    <title>The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis; Tuberculosis; Immune-mediated Inflammatory Disease</condition_summary>
    <last_changed>April 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>968</order>
    <score>0.21848</score>
    <nct_id>NCT03051204</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03051204</url>
    <title>OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Crohn Disease; Ulcerative Colitis; Irritable Bowel Syndrome; Celiac Disease; Healthy</condition_summary>
    <last_changed>February 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>969</order>
    <score>0.21835</score>
    <nct_id>NCT00418340</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00418340</url>
    <title>Manipulation of Visceral Sensitivity and Immune System in IBS</title>
    <status open="N">Unknown status</status>
    <condition_summary>Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Drug: probiotic (bacterial/dietary supplement)</intervention_summary>
    <last_changed>November 15, 2007</last_changed>
  </clinical_study>
  <clinical_study>
    <order>970</order>
    <score>0.21759</score>
    <nct_id>NCT01560377</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01560377</url>
    <title>Perfusion Assessment in Laparoscopic Left Anterior Resection</title>
    <status open="N">Completed</status>
    <condition_summary>Rectal Cancer; Colon Cancer; Crohn's Disease; Polyp; Procidentia; Diverticulitis</condition_summary>
    <intervention_summary>Device: PINPOINT Endoscopic Fluorescence Imaging System</intervention_summary>
    <last_changed>June 30, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>971</order>
    <score>0.21638</score>
    <nct_id>NCT00463580</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00463580</url>
    <title>A Study of Infliximab for Treatment Resistant Major Depression</title>
    <status open="N">Completed</status>
    <condition_summary>Depression</condition_summary>
    <intervention_summary>Drug: infliximab (remicade); Drug: Placebo</intervention_summary>
    <last_changed>October 2, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>972</order>
    <score>0.21484</score>
    <nct_id>NCT01504113</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01504113</url>
    <title>The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis</title>
    <status open="N">Unknown status</status>
    <condition_summary>Psoriasis</condition_summary>
    <last_changed>January 2, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>973</order>
    <score>0.21438</score>
    <nct_id>NCT02171403</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02171403</url>
    <title>Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls</title>
    <status open="N">Completed</status>
    <condition_summary>Lactose Intolerance</condition_summary>
    <last_changed>July 28, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>974</order>
    <score>0.20938</score>
    <nct_id>NCT02283632</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02283632</url>
    <title>A Trial of the Jejunal Diversion Procedure</title>
    <status open="N">Completed</status>
    <condition_summary>Diabetes; Obesity</condition_summary>
    <intervention_summary>Procedure: Jejunal Diversion</intervention_summary>
    <last_changed>June 28, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>975</order>
    <score>0.2072</score>
    <nct_id>NCT01666717</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01666717</url>
    <title>Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <last_changed>August 16, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>976</order>
    <score>0.20672</score>
    <nct_id>NCT01950507</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01950507</url>
    <title>Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Stem Cell Transplantation; Graft vs Host Disease</condition_summary>
    <intervention_summary>Drug: Budesonide; Drug: Fluconazole; Drug: Voriconazole</intervention_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>977</order>
    <score>0.20298</score>
    <nct_id>NCT00810030</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00810030</url>
    <title>FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Anemia; Iron Deficiency; Iron-Deficiency Anemia; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Ferric carboxymaltose; Drug: Iron Sucrose</intervention_summary>
    <last_changed>December 19, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>978</order>
    <score>0.19778</score>
    <nct_id>NCT01545063</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01545063</url>
    <title>CAre of Patients With PArenteral Nutrition At Home</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Peritoneal Carcinomatosis With Intestinal Occlusion; Radiation Enteritis; Chronic Diarrhea; Intestinal Lymphomas</condition_summary>
    <last_changed>July 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>979</order>
    <score>0.19606</score>
    <nct_id>NCT01180868</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01180868</url>
    <title>The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases</title>
    <status open="N">Completed</status>
    <condition_summary>Autoimmune Diseases; Cancer</condition_summary>
    <last_changed>July 27, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>980</order>
    <score>0.19529</score>
    <nct_id>NCT01613001</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01613001</url>
    <title>Obesity as a Risk Factor for Musculoskeletal Diseases in the U.S. Air Force: Associations and Implications for Force Readiness</title>
    <status open="N">Completed</status>
    <condition_summary>Obesity</condition_summary>
    <last_changed>October 15, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>981</order>
    <score>0.19229</score>
    <nct_id>NCT03093064</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03093064</url>
    <title>Inflammatory Response In Schizophrenia</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Schizophrenia</condition_summary>
    <intervention_summary>Drug: Natalizumab; Other: Placebo: normal saline</intervention_summary>
    <last_changed>March 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>982</order>
    <score>0.1908</score>
    <nct_id>NCT00237653</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00237653</url>
    <title>MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus</title>
    <status open="N">Terminated</status>
    <condition_summary>Cytomegalovirus Infections; Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Drug: Valganciclovir</intervention_summary>
    <last_changed>April 2, 2009</last_changed>
  </clinical_study>
  <clinical_study>
    <order>983</order>
    <score>0.19014</score>
    <nct_id>NCT02002286</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02002286</url>
    <title>Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses</title>
    <status open="N">Completed</status>
    <condition_summary>HIV</condition_summary>
    <intervention_summary>Drug: Tripterygium Wilfordii Hook F extract (TwHF extract); Drug: cART</intervention_summary>
    <last_changed>November 29, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>984</order>
    <score>0.18943</score>
    <nct_id>NCT03043677</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03043677</url>
    <title>Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Biological: Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab</intervention_summary>
    <last_changed>February 6, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>985</order>
    <score>0.18608</score>
    <nct_id>NCT02421705</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02421705</url>
    <title>Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)</title>
    <status open="Y">Recruiting</status>
    <condition_summary>IBS; Ulcerative Colitis, Active; Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms); Healthy Controls; Crohn's Disease, Active; Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)</condition_summary>
    <intervention_summary>Other: Sample collection</intervention_summary>
    <last_changed>February 7, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>986</order>
    <score>0.18471</score>
    <nct_id>NCT02806206</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02806206</url>
    <title>Prucalopride Prior to Small Bowel Capsule Endoscopy</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Gastrointestinal Hemorrhage; Crohn Disease; Celiac Disease; Intestinal Diseases; Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Drug: Prucalopride; Drug: Placebo</intervention_summary>
    <last_changed>July 13, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>987</order>
    <score>0.18341</score>
    <nct_id>NCT02128503</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02128503</url>
    <title>Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis; Rheumatic Diseases; Hepatitis B, Chronic</condition_summary>
    <intervention_summary>Other: HBV DNA level monitoring</intervention_summary>
    <last_changed>April 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>988</order>
    <score>0.18233</score>
    <nct_id>NCT00808977</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00808977</url>
    <title>A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Dersalazine sodium; Drug: Mesalazine; Drug: Placebo</intervention_summary>
    <last_changed>November 16, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>989</order>
    <score>0.18033</score>
    <nct_id>NCT00727298</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00727298</url>
    <title>Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)</title>
    <status open="N">Completed</status>
    <condition_summary>Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Psoriasis; Crohn's Disease</condition_summary>
    <intervention_summary>Biological: Infliximab</intervention_summary>
    <last_changed>November 30, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>990</order>
    <score>0.17638</score>
    <nct_id>NCT00622557</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00622557</url>
    <title>General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)</title>
    <status open="N">Unknown status</status>
    <condition_summary>Colon Cancer; Diverticulitis; Colorectal Polyps; Crohn's Disease; Ulcerative Colitis; Rectal Cancer</condition_summary>
    <last_changed>December 11, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>991</order>
    <score>0.17284</score>
    <nct_id>NCT00353639</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00353639</url>
    <title>Telomere Repair Gene Mutation in Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>992</order>
    <score>0.16889</score>
    <nct_id>NCT00286689</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00286689</url>
    <title>Effects of Growth Hormone in Chronically Ill Children</title>
    <status open="N">Unknown status</status>
    <condition_summary>- Hurler Syndrome (MPS-1) With Short Stature and Muscle Wasting; - Cerebral Palsy With Muscle Wasting; - Juvenile Rheumatoid Arthritis With Muscle Wasting and Short Stature; - Crohn’s Disease; - HIV Infection.</condition_summary>
    <intervention_summary>Drug: Growth Hormone; Procedure: Whole body Protein turnover; Procedure: DEXA scan</intervention_summary>
    <last_changed>February 1, 2006</last_changed>
  </clinical_study>
  <clinical_study>
    <order>993</order>
    <score>0.16648</score>
    <nct_id>NCT01126931</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01126931</url>
    <title>Wormwood in Chronic Progressive Disorders With Reduced Appetite</title>
    <status open="N">Unknown status</status>
    <condition_summary>Cancer</condition_summary>
    <last_changed>May 19, 2010</last_changed>
  </clinical_study>
  <clinical_study>
    <order>994</order>
    <score>0.16619</score>
    <nct_id>NCT01034358</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01034358</url>
    <title>Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Uterine Cervical Dysplasia</condition_summary>
    <intervention_summary>Biological: Human Papillomavirus Vaccine</intervention_summary>
    <last_changed>September 21, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>995</order>
    <score>0.16539</score>
    <nct_id>NCT02624037</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02624037</url>
    <title>Precision IFX: Using a Dashboard to Individualize Infliximab Dosage</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: Individualized Dosage Precision IFX Dashboard</intervention_summary>
    <last_changed>November 4, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>996</order>
    <score>0.16405</score>
    <nct_id>NCT01933867</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01933867</url>
    <title>Water-aided Colonoscopy in Inflammatory Bowel Disease Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Procedure: Water immersion; Procedure: Air insufflation insertion</intervention_summary>
    <last_changed>November 16, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>997</order>
    <score>0.16192</score>
    <nct_id>NCT00891787</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00891787</url>
    <title>Probiotic Ingestion and Isoagglutinin Titers</title>
    <status open="N">Completed</status>
    <condition_summary>Isoagglutinin-Mediated Hemolysis; Probiotic Toxicity</condition_summary>
    <intervention_summary>Dietary Supplement: Probiotic Supplement</intervention_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>998</order>
    <score>0.16076</score>
    <nct_id>NCT01067547</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01067547</url>
    <title>A Trial of Iron Replacement in Patients With Iron Deficiency.</title>
    <status open="N">Completed</status>
    <condition_summary>Iron Deficiency; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Iron Sucrose.; Drug: Iron sucrose</intervention_summary>
    <last_changed>April 28, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>999</order>
    <score>0.14832</score>
    <nct_id>NCT01656746</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01656746</url>
    <title>Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Adenomatous Polyp; Crohn Disease; Familial Adenomatous Polyposis; Hereditary Intestinal Polyposis Syndrome; Recurrent Colon Cancer; Stage I Colon Cancer; Stage IIA Colon Cancer; Stage IIB Colon Cancer; Stage IIC Colon Cancer; Stage IIIA Colon Cancer; Stage IIIB Colon Cancer; Stage IIIC Colon Cancer</condition_summary>
    <intervention_summary>Procedure: therapeutic laparoscopic surgery</intervention_summary>
    <last_changed>November 4, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>1000</order>
    <score>0.14679</score>
    <nct_id>NCT02925351</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02925351</url>
    <title>Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Autoimmune Disease; Crohn Disease; Inflammatory Disorder; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Takayasu Arteritis</condition_summary>
    <intervention_summary>Procedure: Computed Tomography; Radiation: Fluorine F 18 Clofarabine; Procedure: Positron Emission Tomography</intervention_summary>
    <last_changed>October 4, 2016</last_changed>
  </clinical_study>
</search_results>
